Use of biologic agents and risk of tuberculosis in Brazil, a tuberculosis high-burden country
Background: Brazil is a country with a high burden of tuberculosis (TB). The immunomodulatory effect of biological therapies is associated with an increased risk of infection. This study evaluated the frequency of TB infection in patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS),...
Main Authors: | Fernanda Gomes Gonçalves Chaer, Juliana Miranda de Lucena Valim, Rogério Castro Reis, Giselle Burlamaqui Klautau, Branca Dias Batista de Souza |
---|---|
Format: | Article |
Language: | English |
Published: |
BioExcel Publishing Ltd
2020-07-01
|
Series: | Drugs in Context |
Subjects: | |
Online Access: | ttps://www.drugsincontext.com/use-of-biologic-agents-and-risk-of-tuberculosis-in-brazil,-a-tuberculosis-high-burden-country |
Similar Items
-
Tuberculosis screening in patients receiving biological therapy
by: Sara Ramos, et al.
Published: (2015-07-01) -
Diagnosis and Treatment of Latent Tuberculosis Infection in Patients with Inflammatory Bowel Diseases due to Initiation of Anti-Tumor Necrosis Factor Therapy
by: Tae Sun Shim
Published: (2014-01-01) -
Utility of interferon gamma/tumor necrosis factor alpha FluoroSpot assay in differentiation between active tuberculosis and latent tuberculosis infection: a pilot study
by: Lifan Zhang, et al.
Published: (2021-07-01) -
Latent tuberculosis infection in patients with rheumatic diseases
by: Camila Anton, et al.
Published: (2019-04-01) -
Evaluation of Immigrant Tuberculosis Screening in Industrialized Countries
by: Manish Pareek, et al.
Published: (2012-09-01)